Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 46201-46250 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06105489
"Tunnel Flap vs Trapezoidal Flap for Lateral Sinus Lift"
NA
Recruiting
36 participants
Started: Oct 21, 2022 · Completed: Oct 21, 2026
1 condition
1 sponsor
1 location
NCT06425848
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
N/A
Recruiting
2,000 participants
Started: Oct 21, 2022 · Completed: Dec 31, 2030
1 condition
1 sponsor
12 locations
NCT05535088
Older Adults Virtual Reality
NA
Recruiting
35 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05408754
Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation
NA
Recruiting
78 participants
Started: Oct 20, 2022 · Completed: May 1, 2025
1 condition
1 sponsor
6 locations
NCT05685836
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
N/A
Recruiting
15 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05190978
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction
NA
Recruiting
120 participants
Started: Oct 20, 2022 · Completed: Apr 30, 2026
2 conditions
7 sponsors
1 location
NCT05652374
Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study
PHASE4
Recruiting
100 participants
Started: Oct 20, 2022 · Completed: Oct 31, 2027
1 condition
3 sponsors
3 locations
NCT05496348
Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis
N/A
Recruiting
400 participants
Started: Oct 20, 2022 · Completed: Aug 31, 2027
1 condition
1 sponsor
94 locations
NCT04931979
SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy
PHASE2
Recruiting
49 participants
Started: Oct 20, 2022 · Completed: Apr 1, 2026
2 conditions
2 sponsors
1 location
NCT05500586
The Effects of Glucagon on Hepatic Metabolism
PHASE1/PHASE2
Recruiting
60 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05390918
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
NA
Recruiting
190 participants
Started: Oct 20, 2022 · Completed: Jul 31, 2026
3 conditions
2 sponsors
1 location
NCT05086250
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
EARLY_PHASE1
Recruiting
20 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT04535050
DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications
NA
Recruiting
100 participants
Started: Oct 20, 2022 · Completed: Apr 15, 2026
3 conditions
1 sponsor
1 location
NCT05598034
Evaluating tDCS Brain-stimulation in Depression Using MRI
NA
Recruiting
144 participants
Started: Oct 20, 2022 · Completed: May 1, 2027
1 condition
2 sponsors
1 location
NCT05571774
Construction of a Database for TTP
N/A
Recruiting
500 participants
Started: Oct 20, 2022 · Completed: Oct 20, 2028
1 condition
1 sponsor
1 location
NCT05547321
Efficacy and Safety Study of OMTX705, Monotherapy and Pembrolizumab-combined, in Subjects With Advanced Solid Tumors.
PHASE1
Recruiting
120 participants
Started: Oct 20, 2022 · Completed: Oct 31, 2024
1 condition
1 sponsor
8 locations
NCT05950698
Obesity and Bariatric Surgery According to a Biopsychosocial Perspective.
N/A
Recruiting
50 participants
Started: Oct 20, 2022 · Completed: Oct 20, 2026
5 conditions
3 sponsors
1 location
NCT05122728
Post-Concussion Musculoskeletal Injury Risks
N/A
Recruiting
148 participants
Started: Oct 20, 2022 · Completed: Dec 1, 2025
1 condition
3 sponsors
3 locations
NCT05566392
Longterm Influence of Pediatric Long COVID Syndrome
N/A
Recruiting
500 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT05259839
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
PHASE1
Recruiting
320 participants
Started: Oct 20, 2022 · Completed: Sep 30, 2033
1 condition
1 sponsor
49 locations
NCT05049148
Platelets Activation in Brain Neoplasms
NA
Recruiting
50 participants
Started: Oct 20, 2022 · Completed: Jan 20, 2028
4 conditions
1 sponsor
1 location
NCT05500469
Endothelial Cell Loss in Pseudophakic Patients Receiving a Paul Glaucoma Drainage Device With Its Tube Inserted in the Anterior Versus Posterior Chamber: a Randomized Controlled Trial
NA
Recruiting
200 participants
Started: Oct 20, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT06231446
Extracorporeal Membrane Oxygenation for Respiratory Failure Patients
N/A
Recruiting
400 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05581004
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
PHASE1
Recruiting
450 participants
Started: Oct 20, 2022 · Completed: Feb 28, 2027
12 conditions
1 sponsor
41 locations
NCT05232630
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
PHASE4
Recruiting
20 participants
Started: Oct 20, 2022 · Completed: Jun 20, 2025
6 conditions
2 sponsors
1 location
NCT05586022
Risk Factors for Adverse Outcomes of Endovascular Revascularization in Lower Extremity Arteriosclerosis Occlusion
N/A
Recruiting
500 participants
Started: Oct 20, 2022 · Completed: Dec 1, 2024
1 condition
1 sponsor
1 location
NCT06170268
Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
N/A
Recruiting
20,000 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2032
1 condition
5 sponsors
1 location
NCT05595590
Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer
PHASE2
Recruiting
20 participants
Started: Oct 20, 2022 · Completed: Oct 19, 2026
1 condition
1 sponsor
2 locations
NCT05611593
Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia
PHASE1
Recruiting
90 participants
Started: Oct 20, 2022 · Completed: Feb 28, 2025
1 condition
1 sponsor
3 locations
NCT05493163
Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism
PHASE4
Recruiting
558 participants
Started: Oct 19, 2022 · Completed: Jan 31, 2028
1 condition
9 sponsors
1 location
NCT05861752
Paraphilic Disorders and Other Conditions with Risk for Sexual Violence: a Case-control Study
N/A
Recruiting
240 participants
Started: Oct 19, 2022 · Completed: Oct 19, 2037
3 conditions
2 sponsors
1 location
NCT05344651
Comparing the Baerveldt and Paul Glaucoma Drainage Devices and Their Effects on the Corneal Endothelium
NA
Recruiting
160 participants
Started: Oct 19, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05605197
U87 CART in Treatment of Advanced Solid Tumor
PHASE1
Recruiting
12 participants
Started: Oct 19, 2022 · Completed: Oct 8, 2025
2 conditions
2 sponsors
1 location
NCT04869683
Biocollection in MyeloDysplastic Syndrome (P-MDS)
NA
Recruiting
150 participants
Started: Oct 19, 2022 · Completed: Oct 19, 2032
6 conditions
1 sponsor
1 location
NCT05626985
Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma
N/A
Recruiting
2,000 participants
Started: Oct 19, 2022 · Completed: Dec 31, 2024
1 condition
2 sponsors
3 locations
NCT05599685
A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer
N/A
Recruiting
150 participants
Started: Oct 19, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT04755413
The Precision CAD Trial
NA
Recruiting
450 participants
Started: Oct 19, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
5 locations
NCT06955208
3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
NA
Recruiting
300 participants
Started: Oct 19, 2022 · Completed: Oct 9, 2026
1 condition
1 sponsor
1 location
NCT04972799
Evaluation of the Efficacy and Safety of Autologous Fat Injection Into the Intersphincter Space in Fecal Incontinence: a Randomized, Placebo-controlled, Cross-over, Double-blind Trial
NA
Recruiting
50 participants
Started: Oct 19, 2022 · Completed: Nov 30, 2027
1 condition
1 sponsor
3 locations
NCT06522815
Updating Deep Learning Algorithms for OSA Monitoring
NA
Recruiting
107 participants
Started: Oct 19, 2022 · Completed: Jul 11, 2025
2 conditions
2 sponsors
1 location
NCT05397197
Impact of Moderate Preterm Birth on Vocabulary Acquisition
NA
Recruiting
160 participants
Started: Oct 19, 2022 · Completed: Oct 18, 2027
1 condition
1 sponsor
1 location
NCT06805552
Sarcopenia and Systemic Therapy in HCC
N/A
Recruiting
270 participants
Started: Oct 19, 2022 · Completed: Nov 1, 2025
1 condition
2 sponsors
1 location
NCT04991025
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
PHASE2
Recruiting
60 participants
Started: Oct 19, 2022 · Completed: Oct 31, 2026
3 conditions
1 sponsor
7 locations
NCT06239584
Generation of Lung Tumor Organoids From Patients Undergoing Diagnostic Bronchoscopy
NA
Recruiting
30 participants
Started: Oct 19, 2022 · Completed: Feb 2, 2024
1 condition
2 sponsors
1 location
NCT05566561
Para-sartorial Compartment Block in Knee Surgery
NA
Recruiting
60 participants
Started: Oct 19, 2022 · Completed: Dec 16, 2025
4 conditions
1 sponsor
1 location
NCT04930653
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
PHASE2
Recruiting
34 participants
Started: Oct 19, 2022 · Completed: Jun 15, 2028
8 conditions
2 sponsors
3 locations
NCT05368428
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer
NA
Recruiting
27 participants
Started: Oct 19, 2022 · Completed: Mar 31, 2027
22 conditions
2 sponsors
3 locations
NCT05692739
Clinical Trial to Determine the Effectiveness and Safety of Topical Insulin in Dry Eye
PHASE4
Recruiting
120 participants
Started: Oct 19, 2022 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT05687968
Innovative Approaches in Diabetes Care
NA
Recruiting
39 participants
Started: Oct 19, 2022 · Completed: Oct 1, 2025
3 conditions
1 sponsor
1 location
NCT06017011
Clinico-Radiological Characterisation for Remission of Acute Charcot-Neuroarthropathy of Foot.
N/A
Recruiting
25 participants
Started: Oct 19, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
Previous
1
More pages
922
923
924
925
926
927
928
More pages
1333
Next